Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2022-01-07 | 2022-02-18 | 152304 |
APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2022-01-21 | 2022-02-18 | 153291 |
APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2021-10-15 | 2022-02-19 | 147289 |
APO-CEPHALEX | 500MG | TABLET | Resolved | 2022-02-11 | 2022-02-22 | 154753 |
APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2022-02-11 | 2022-02-22 | 154759 |
APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2022-02-11 | 2022-02-22 | 154756 |
APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2022-02-04 | 2022-02-22 | 154175 |
APO-MODAFINIL | 100MG | TABLET | Resolved | 2022-02-04 | 2022-02-22 | 154181 |
APO-ONDANSETRON | 4MG | TABLET | Resolved | 2021-10-29 | 2022-02-28 | 148509 |
APO-ONDANSETRON | 4MG | TABLET | Resolved | 2022-02-04 | 2022-02-28 | 154184 |
APO-ONDANSETRON | 8MG | TABLET | Resolved | 2021-10-08 | 2022-02-28 | 146907 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2022-01-21 | 2022-02-28 | 153288 |
APO-SIMVASTATIN | 20MG | TABLET | Resolved | 2021-07-23 | 2022-03-01 | 142985 |
APO-RISEDRONATE | 150MG | TABLET | Resolved | 2021-09-10 | 2022-03-04 | 145468 |
APO-RISEDRONATE | 150MG | TABLET | Resolved | 2022-02-04 | 2022-03-07 | 154197 |
TRI-CIRA LO 21 | 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG | TABLET | Resolved | 2022-02-22 | 2022-03-07 | 155371 |
APO-DONEPEZIL | 10MG | TABLET | Resolved | 2022-03-04 | 2022-03-09 | 156033 |
APO-TRYPTOPHAN | 1G | TABLET | Resolved | 2022-01-21 | 2022-03-09 | 153294 |
APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2022-02-22 | 2022-03-09 | 155365 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2022-02-22 | 2022-03-11 | 155362 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
APO-LOSARTAN | 50MG | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 60987 |
APO-MEDROXY TABLETS | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60609 |
APO-MELOXICAM | 7.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60612 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-MEMANTINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60615 |
APO-MYCOPHENOLATE | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60637 |
APO-NAPRO-NA | 275MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60657 |
APO-NAPRO-NA DS | 550MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60660 |
APO-NAPROXEN | 250MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60666 |
APO-PAROXETINE | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60684 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |